Showing results (551-560 of 887) with videos related to
Sort By:
Pageof 89
Arteriosclerosis, Thrombosis, and Vascular Biology|November 8, 2008
Potent and selective PPAR-alpha agonist LY518674 upregulates both ApoA-I production and catabolism in human subjects with the metabolic syndromeJohn S Millar, Danielle Duffy, Ramprasad Gadi, et al.Journal of the American College of Cardiology|February 21, 2012
Translational studies of lipoprotein-associated phospholipase A₂ in inflammation and atherosclerosisJane F Ferguson, Christine C Hinkle, Nehal N Mehta, et al.Autism : the International Journal of Research and Practice|February 5, 2026
Sleep and activity patterns in autismJ Dylan Weissenkampen, Arpita Ghorai, Thaise Nr Carneiro, et al.Diabetologia|July 25, 2020
Type 1 diabetes in Africa: an immunogenetic study in the Amhara of North-West EthiopiaShitaye A Balcha, Abayneh G Demisse, Rajashree Mishra, et al.Nature Genetics|August 13, 2021
Mapping the genetic architecture of human traits to cell types in the kidney identifies mechanisms of disease and potential treatmentsXin Sheng, Yuting Guan, Ziyuan Ma, et al.Journal of Lipid Research|September 6, 2017
Polygenic determinants in extremes of high-density lipoprotein cholesterolJacqueline S Dron, Jian Wang, Cécile Low-Kam, et al.Nature Genetics|June 2, 2026
Integrative analyses elucidate transcriptional regulatory functions of risk alleles for metabolic liver diseaseBiying Zhu, Na He, Yang Xiao, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|March 12, 2005
Effects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies, apolipoprotein A-I metabolism, and fecal sterol excretionMargaret E Brousseau, Margaret R Diffenderfer, John S Millar, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|April 1, 2006
Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humansJohn S Millar, Margaret E Brousseau, Margaret R Diffenderfer, et al.Circulation. Genomic and Precision Medicine|January 14, 2020
Prospective CYP2C19 Genotyping to Guide Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Pragmatic Randomized Clinical TrialSony Tuteja, Henry Glick, William Matthai, et al.Pageof 89